These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 23528938)
1. The innate immune system of the perinatal lung and responses to respiratory syncytial virus infection. Derscheid RJ; Ackermann MR Vet Pathol; 2013 Sep; 50(5):827-41. PubMed ID: 23528938 [TBL] [Abstract][Full Text] [Related]
2. Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles. Garlapati S; Garg R; Brownlie R; Latimer L; Simko E; Hancock RE; Babiuk LA; Gerdts V; Potter A; van Drunen Littel-van den Hurk S Vaccine; 2012 Jul; 30(35):5206-14. PubMed ID: 22713718 [TBL] [Abstract][Full Text] [Related]
4. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. Garg R; Shrivastava P; van Drunen Littel-van den Hurk S Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388 [TBL] [Abstract][Full Text] [Related]
5. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally. Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Kurokawa M J Med Virol; 2010 May; 82(6):1075-82. PubMed ID: 20419825 [TBL] [Abstract][Full Text] [Related]
13. Immunopathology of RSV infection: prospects for developing vaccines without this complication. van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293 [TBL] [Abstract][Full Text] [Related]
14. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. Krishnan S; Craven M; Welliver RC; Ahmad N; Halonen M J Infect Dis; 2003 Aug; 188(3):433-9. PubMed ID: 12870126 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity. Ostler T; Ehl S Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340 [TBL] [Abstract][Full Text] [Related]
16. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Piedimonte G Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455 [TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus infection and immunity. González PA; Bueno SM; Carreño LJ; Riedel CA; Kalergis AM Rev Med Virol; 2012 Jul; 22(4):230-44. PubMed ID: 22290692 [TBL] [Abstract][Full Text] [Related]
19. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands. Shafique M; Wilschut J; de Haan A Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195 [TBL] [Abstract][Full Text] [Related]
20. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice. Lambert AL; Trasti FS; Mangum JB; Everitt JI Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]